The number of multidrug-resistant tuberculosis (MDR-TB) cases started on treatment in Brazil is forecasted to increase consistently from 911 cases in 2024 to 1,020 cases by 2028. This translates to a year-on-year increase of approximately 3% to 4%. The compound annual growth rate (CAGR) for the 2024 to 2028 period stands at around 2.8%, indicating a steady rise in cases treated each year.
Future trends to watch for include advancements in treatment protocols and the potential impact of new public health strategies on MDR-TB case management. Monitoring the development of healthcare infrastructure and the accessibility of treatment options will be crucial in the coming years.
